Patent: 10,322,086
✉ Email this page to a colleague
Summary for Patent: 10,322,086
Title: | Methods of treating arthritis |
Abstract: | The present invention provides methods of treating arthritis. A sustained release composition comprising liposomes and one or more therapeutic agent or a pharmaceutically acceptable salt thereof is administered to a subject in need thereof. The liposomes may be in an aqueous suspension. The sustained release composition can be administered intraarticularly. |
Inventor(s): | Hong; Keelung (South San Francisco, CA), Guo; Luke S. S. (South San Francisco, CA), Tseng; Yun-Long (Taipei, TW), Shih; Sheue-Fang (Taipei, TW), Chang; Po-Chun (Taipei, TW), Tsai; Chih-Chiang (Taipei, TW), Lin; Hong-Hui (Taipei, TW) |
Assignee: | TLC BIOPHARMACEUTICALS, INC. (South San Francisco, CA) TAIWAN LIPOSOME COMPANY, LTD. (Taipei, TW) |
Application Number: | 15/695,649 |
Patent Claims: | see list of patent claims |
Details for Patent 10,322,086
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 11/02/1998 | ⤷ Try a Trial | 2032-07-05 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 05/27/1999 | ⤷ Try a Trial | 2032-07-05 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 09/27/2004 | ⤷ Try a Trial | 2032-07-05 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 02/01/2007 | ⤷ Try a Trial | 2032-07-05 |
Immunex Corporation | ENBREL MINI | etanercept | Injection | 103795 | 09/14/2017 | ⤷ Try a Trial | 2032-07-05 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |